SC-20 Dyslipidemia and real-life prescription of statins among people living With HIV enrolled in archi prevaleat cohort
Benedetto Maurizio Celesia(Ospedale Garibaldi), Paolo Maggi(Università degli Studi di Enna Kore), Addolorata Masiello(University of Campania "Luigi Vanvitelli"), Alessandra Tartaglia(University of Foggia), Domenico Angiletta, Luca Galli(University of Pisa), Antonella Castagna(Vita-Salute San Raffaele University), Giovanni Di Filippo(Federico II University Hospital), Sergio Zacà(University of Bari Aldo Moro), Salvatore Martini(University of Campania "Luigi Vanvitelli"), MS Paternò Raddusa(University of Catania), ED Ricci(Fondazione Roma), Camilla Muccini(Vita-Salute San Raffaele University), Sergio Ferrara(University of Turin), R. Basile(Azienda ospedaliera "Bianchi-Melacrino-Morelli")
Cited by 0
Related Papers
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
|New England Journal of Medicine|2022|312
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
|Critical Care and Resuscitation|2020|229